Detection of Prostate Cancer Proteins in Serum for Cancer Diagnosis with a Blood Test

Case ID:

C10088

Disclosure Date:

6/2/2007

There is a crucial need of discovering novel biomarkers in addition to prostate specific antigen (PSA) to improve the specificity of clinical diagnosis for prostate cancer. This invention addresses this problem by discovering proteins from prostate cancer tissues that can be detected in patients’ blood. Hence, a blood test can be developed for detecting prostate cancer at an early, more curable stage, and to molecularly define the cancer stage for an accurate prognosis. Additional advantages of this discovery include:

• Diagnostic markers for prostate cancer risk assessment
• Potential development of novel therapeutic strategies

Publications: US8603734

Patent Information:

Title	App Type	Country	Serial No.	Patent No.	File Date	Issued Date	Expire Date	Patent Status
Biomarkers for Prostate Cancer	PCT: Patent Cooperation Treaty	United States	12/663,191	8,603,734	6/14/2010	12/10/2013	6/4/2028	Granted

Direct Link:

https://jhu.technologypublisher.com/technology/45186

Inventors:

Category(s):

Clinical and Disease Specializations, Clinical and Disease Specializations > Men's Health, Technology Classifications > Diagnostics > In Vitro Diagnostics, Technology Classifications > Research Tools > Assays, Technology Classifications > Diagnostics, Clinical and Disease Specializations > Oncology, Technology Classifications > Research Tools, Clinical and Disease Specializations > Oncology > Prostate Cancer,

Get custom alerts for techs in these categories/from these inventors:

Subscribe for JHTV Updates

For Information, Contact:

Nakisha Holder

nickki@jhu.edu

410-614-0300

Save This Technology:

Bookmark this page

Download as PDF